Zinnia Li, based in San Mateo, CA, US, is currently a Senior Director, Head of Analytical Development and QC at REVOLUTION Medicines, bringing experience from previous roles at Corcept Therapeutics, Gilead Sciences, ArQule and Sunovion Pharmaceuticals. Zinnia Li holds a 1999 - 2005 Ph.D. in Physical/Analytical Chemistry @ Boston University. With a robust skill set that includes Technology Transfer, IR, IND, Laboratory, Bioanalysis and more, Zinnia Li contributes valuable insights to the industry. Zinnia Li has 3 emails and 1 mobile phone number on RocketReach.